Reliq Health Technologies Inc.
RQHTF · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.03 | 10.32 | 2.30 | -1.10 |
| FCF Yield | -0.00% | -2.73% | -1.34% | -1.79% |
| EV / EBITDA | 140.42 | -1,291.09 | -142.77 | -94.54 |
| Quality | ||||
| ROIC | 4.52% | -0.06% | -8.52% | -18.74% |
| Gross Margin | 67.53% | 34.42% | 13.42% | 23.36% |
| Cash Conversion Ratio | -1.69 | 37.56 | 10.89 | 1.62 |
| Growth | ||||
| Revenue 3-Year CAGR | 138.89% | 125.04% | 113.48% | 95.58% |
| Free Cash Flow Growth | 99.95% | -100.66% | 17.02% | -9.64% |
| Safety | ||||
| Net Debt / EBITDA | -0.08 | 0.63 | -0.25 | -0.18 |
| Interest Coverage | 115.95 | -1.02 | -128.55 | -153.63 |
| Efficiency | ||||
| Inventory Turnover | 2.54 | 8.31 | 9.19 | 6.44 |
| Cash Conversion Cycle | -48.47 | 104.12 | 122.34 | 111.37 |